GB2234169B - A method for preparing a sustained-release pharmaceutical peptide composition - Google Patents

A method for preparing a sustained-release pharmaceutical peptide composition

Info

Publication number
GB2234169B
GB2234169B GB9015722A GB9015722A GB2234169B GB 2234169 B GB2234169 B GB 2234169B GB 9015722 A GB9015722 A GB 9015722A GB 9015722 A GB9015722 A GB 9015722A GB 2234169 B GB2234169 B GB 2234169B
Authority
GB
United Kingdom
Prior art keywords
sustained
preparing
release pharmaceutical
peptide composition
pharmaceutical peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
GB9015722A
Other languages
English (en)
Other versions
GB2234169A (en
GB9015722D0 (en
Inventor
Piero Orsolini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Debiopharm SA
Original Assignee
Debiopharm SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debiopharm SA filed Critical Debiopharm SA
Publication of GB9015722D0 publication Critical patent/GB9015722D0/en
Publication of GB2234169A publication Critical patent/GB2234169A/en
Application granted granted Critical
Publication of GB2234169B publication Critical patent/GB2234169B/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB9015722A 1989-07-28 1990-07-17 A method for preparing a sustained-release pharmaceutical peptide composition Expired - Lifetime GB2234169B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH2829/89A CH679207A5 (enExample) 1989-07-28 1989-07-28

Publications (3)

Publication Number Publication Date
GB9015722D0 GB9015722D0 (en) 1990-09-05
GB2234169A GB2234169A (en) 1991-01-30
GB2234169B true GB2234169B (en) 1993-02-10

Family

ID=4242536

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9015722A Expired - Lifetime GB2234169B (en) 1989-07-28 1990-07-17 A method for preparing a sustained-release pharmaceutical peptide composition

Country Status (23)

Country Link
US (1) US5134122A (enExample)
JP (1) JPH0662427B2 (enExample)
AT (1) AT397197B (enExample)
AU (1) AU619996B2 (enExample)
BE (1) BE1003093A3 (enExample)
CA (1) CA2021767C (enExample)
CH (1) CH679207A5 (enExample)
DE (1) DE4023134C2 (enExample)
DK (1) DK175495B1 (enExample)
ES (1) ES2020890A6 (enExample)
FI (1) FI97688C (enExample)
FR (1) FR2650182B1 (enExample)
GB (1) GB2234169B (enExample)
GR (1) GR1001215B (enExample)
IE (1) IE65397B1 (enExample)
IL (1) IL95120A (enExample)
IT (1) IT1243357B (enExample)
LU (1) LU87772A1 (enExample)
NL (1) NL194858C (enExample)
NO (1) NO300304B1 (enExample)
PT (1) PT94842B (enExample)
SE (1) SE504279C2 (enExample)
ZA (1) ZA905654B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263108B2 (en) 2001-06-22 2012-09-11 Durect Corporation Zero-order prolonged release coaxial implants

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH30995A (en) * 1989-07-07 1997-12-23 Novartis Inc Sustained release formulations of water soluble peptides.
US5538739A (en) * 1989-07-07 1996-07-23 Sandoz Ltd. Sustained release formulations of water soluble peptides
CH681425A5 (enExample) * 1990-11-14 1993-03-31 Debio Rech Pharma Sa
DE69133136T2 (de) * 1990-05-16 2003-06-18 Southern Research Institute, Birmingham Mikrokapseln mit gesteuerter freigabe sowie deren verwendung zur stimulierung des nervenfaserwachstums
US6517859B1 (en) 1990-05-16 2003-02-11 Southern Research Institute Microcapsules for administration of neuroactive agents
CH683149A5 (fr) * 1991-07-22 1994-01-31 Debio Rech Pharma Sa Procédé pour la préparation de microsphères en matériau polymère biodégradable.
WO1993015722A1 (en) * 1992-02-07 1993-08-19 Syntex (Usa) Inc. Controlled delivery of pharmaceuticals from preformed porous microparticles
US6013853A (en) * 1992-02-14 2000-01-11 The University Of Texas System Continuous release polymeric implant carrier
US5876452A (en) * 1992-02-14 1999-03-02 Board Of Regents, University Of Texas System Biodegradable implant
GB9211268D0 (en) * 1992-05-28 1992-07-15 Ici Plc Salts of basic peptides with carboxyterminated polyesters
US5456917A (en) * 1993-04-12 1995-10-10 Cambridge Scientific, Inc. Method for making a bioerodible material for the sustained release of a medicament and the material made from the method
DE4342092B4 (de) * 1993-12-09 2007-01-11 Zentaris Gmbh Langwirkende Injektionssuspension und Verfahren zur Herstellung
CA2178592C (en) * 1993-12-09 2009-07-28 Jurgen Engel Long-acting injection suspensions and a process for their preparation
US5569468A (en) * 1994-02-17 1996-10-29 Modi; Pankaj Vaccine delivery system for immunization, using biodegradable polymer microspheres
US5417982A (en) * 1994-02-17 1995-05-23 Modi; Pankaj Controlled release of drugs or hormones in biodegradable polymer microspheres
US5430021A (en) * 1994-03-18 1995-07-04 Pharmavene, Inc. Hydrophobic drug delivery systems
US5595760A (en) * 1994-09-02 1997-01-21 Delab Sustained release of peptides from pharmaceutical compositions
FR2748205A1 (fr) 1996-05-06 1997-11-07 Debio Rech Pharma Sa Compositions pharmaceutiques pour la liberation controlee de principes actifs insolubles
US5945128A (en) * 1996-09-04 1999-08-31 Romano Deghenghi Process to manufacture implants containing bioactive peptides
CA2267930A1 (en) * 1996-10-09 1998-04-16 Nobuyuki Takechi A method for producing a microparticle
WO1998032423A1 (en) * 1997-01-29 1998-07-30 Takeda Chemical Industries, Ltd. Sustained-release microspheres, their production and use
US6071982A (en) * 1997-04-18 2000-06-06 Cambridge Scientific, Inc. Bioerodible polymeric semi-interpenetrating network alloys for surgical plates and bone cements, and method for making same
WO1999024061A1 (en) 1997-11-07 1999-05-20 Chiron Corporation Method for producing igf-1 sustained-release formulations
IT1304152B1 (it) * 1998-12-10 2001-03-08 Mediolanum Farmaceutici Srl Composizioni comprendenti un peptide ed acido polilattico-glicolicoatte alla preparazione di impianti sottocutanei aventi un prolungato
EA004502B1 (ru) * 1998-12-16 2004-04-29 Авентис Фармасьютикалз Инк. Фармацевтическая композиция антагониста рецептора серотонина и способ ее получения
US6455526B1 (en) 1998-12-16 2002-09-24 Aventis Pharmaceuticals, Inc. Biodegradable polymer encapsulated pharmaceutical compositions and method for preparing the same
EP1156781B1 (en) 1999-02-26 2005-06-08 Chiron Corporation Microemulsions with adsorbed macromolecules and microparticles
US7713739B1 (en) * 2000-11-17 2010-05-11 Novartis Vaccines And Diagnostics, Inc. Microparticle-based transfection and activation of dendritic cells
ES2169980B1 (es) 1999-12-17 2003-11-01 Lipotec Sa Microcapsulas para la liberacion prolongada de farmacos.
US6362308B1 (en) 2000-08-10 2002-03-26 Alkermes Controlled Therapeutics Inc. Ii Acid end group poly(d,l-lactide-co-glycolide) copolymers high glycolide content
WO2002087586A1 (en) * 2001-04-26 2002-11-07 Control Delivery Systems, Inc. Sustained release drug delivery system containing codrugs
US20040022853A1 (en) * 2001-04-26 2004-02-05 Control Delivery Systems, Inc. Polymer-based, sustained release drug delivery system
CA2449502C (en) * 2001-05-23 2010-10-12 Hexal Ag Homogenate for implants and microparticles
IN2014DN10834A (enExample) * 2001-09-17 2015-09-04 Psivida Inc
KR101041767B1 (ko) * 2002-06-25 2011-06-17 다케다 야쿠힌 고교 가부시키가이샤 서방성 조성물의 제조 방법
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
BRPI0407071B8 (pt) 2003-01-28 2021-05-25 Ironwood Pharmaceuticals Inc peptídeo purificado, seu método de produção e composição farmacêutica para o tratamento de distúrbios gastrointestinais
GB0304726D0 (en) * 2003-03-01 2003-04-02 Ardana Bioscience Ltd New Process
EP1617859A1 (en) * 2003-04-30 2006-01-25 Debiopharm S.A. Methods and compositions using gonadotropin hormone releasing hormone
WO2005020933A2 (en) * 2003-09-02 2005-03-10 University Of South Florida Nanoparticles for drug-delivery
AU2004287875B2 (en) 2003-11-05 2011-06-02 Bausch + Lomb Ireland Limited Modulators of cellular adhesion
WO2005063276A1 (en) * 2003-12-23 2005-07-14 Debiopharm S.A. Methods and compositions using gonadotropin hormone releasing hormone
FR2865938B1 (fr) * 2004-02-05 2006-06-02 Sod Conseils Rech Applic Formulation retard solide comprenant de l'acetate de triptoreline
US8541028B2 (en) 2004-08-04 2013-09-24 Evonik Corporation Methods for manufacturing delivery devices and devices thereof
JP2008511420A (ja) 2004-08-30 2008-04-17 スピネオベイションズ・インコポレーテッド 脊髄の椎間板内障害の治療の方法
EP1674082A1 (de) * 2004-12-22 2006-06-28 Zentaris GmbH Verfahren zur Herstellung von sterilen Suspensionen oder Lyophilisaten schwerlöslicher basischer Peptidkomplexe, diese enthaltende pharmazeutische Formulierungen sowie ihre Verwendung als Arzneimittel
WO2006125119A1 (en) 2005-05-17 2006-11-23 Sarcode Corporation Compositions and methods for treatment of eye disorders
KR100722607B1 (ko) * 2006-05-11 2007-05-28 주식회사 펩트론 분산성 및 주사 투여능이 향상된 서방성 미립구의 제조방법
DK2170930T3 (da) 2007-06-04 2012-11-05 Synergy Pharmaceuticals Inc Agonister af guanylatcyclase, anvendelige til behandlingen af gastrointestinale sygdomme, inflammation, cancer og andre sygdomme
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
PT2500014T (pt) * 2007-06-06 2018-11-21 Debiopharm Int Sa Composição farmacêutica de libertação prolongada constituída por micropartículas
CN101873797A (zh) 2007-10-19 2010-10-27 萨可德公司 用于治疗糖尿病性视网膜病的组合物和方法
EP2222281B1 (en) 2007-12-20 2018-12-05 Evonik Corporation Process for preparing microparticles having a low residual solvent volume
US8469961B2 (en) * 2008-03-05 2013-06-25 Neville Alleyne Methods and compositions for minimally invasive capsular augmentation of canine coxofemoral joints
US20100010549A1 (en) * 2008-03-05 2010-01-14 Neville Alleyne device and method of minimally invasive extracapsular ligamentous augmentation for canine stifle ligament injuries
EP2276508A4 (en) * 2008-04-15 2011-12-28 Sarcode Bioscience Inc ADMINISTRATION OF LFA-1 ANTAGONISTS TO THE GASTROINTESTINAL SYSTEM
US8080562B2 (en) 2008-04-15 2011-12-20 Sarcode Bioscience Inc. Crystalline pharmaceutical and methods of preparation and use thereof
EP2328910B1 (en) 2008-06-04 2014-08-06 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
JP2012524779A (ja) * 2009-04-23 2012-10-18 サステインド ナノ システムズ リミテッド ライアビリティ カンパニー 制御放出分配デバイス
WO2011050175A1 (en) 2009-10-21 2011-04-28 Sarcode Corporation Crystalline pharmaceutical and methods of preparation and use thereof
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
KR101411349B1 (ko) 2010-12-24 2014-06-25 주식회사 삼양바이오팜 생리활성 펩타이드를 포함하는 마이크로입자 및 그의 제조방법, 및 그를 포함하는 약제학적 조성물
CA2835018C (en) 2011-05-04 2020-04-21 Balance Therapeutics, Inc. Pentylenetetrazole derivatives
EP2630964A1 (en) 2012-02-22 2013-08-28 Immundiagnostik AG Method and medicament for treating patients in risk of prediabetes and type-2 diabetes
MX356545B (es) * 2012-05-14 2018-06-01 Teijin Ltd Composicion esteril.
EP4406950A3 (en) 2012-07-25 2025-04-23 Bausch + Lomb Ireland Limited Lfa-1 inhibitor and polymorph thereof
US9545446B2 (en) 2013-02-25 2017-01-17 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
CA2905438A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
US9486494B2 (en) 2013-03-15 2016-11-08 Synergy Pharmaceuticals, Inc. Compositions useful for the treatment of gastrointestinal disorders
CN105792838A (zh) * 2013-10-08 2016-07-20 辉凌公司 通过pgss制备的包含gnrh的微粒
MY176976A (en) 2013-10-10 2020-08-28 Bausch Health Ireland Ltd Agonists of guanylate cyclase useful for the treatment of opioid induced dysfunctions
JP2018505726A (ja) 2015-01-16 2018-03-01 スピネオベイションズ・インコーポレーテッド 脊椎円板を処置する方法
JP2019506383A (ja) 2016-01-11 2019-03-07 シナジー ファーマシューティカルズ インコーポレイテッド 潰瘍性大腸炎を治療するための製剤および方法
EP3651771B1 (en) 2017-07-11 2023-08-30 Sustained Nano Systems LLC Radiation sterilization of hypercompressed polymer dosage forms
WO2019014280A1 (en) 2017-07-11 2019-01-17 Sustained Nano Systems Llc HYDRO-PRESSED PHARMACEUTICAL FORMULATIONS
JP2020535224A (ja) 2017-09-26 2020-12-03 ナノミ・ベー・フェー 二重エマルション技術によるマイクロ粒子を調製する方法
WO2021185373A1 (zh) * 2020-03-20 2021-09-23 苏州医本生命科技有限公司 载药用微粒、载药微粒、蓄粒管及其植入系统
WO2024250012A2 (en) 2023-06-02 2024-12-05 33 Medical, Inc. Compositions for treatment of discogenic pain, and processes for making and using the same

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4483807A (en) * 1981-01-27 1984-11-20 Japan Atomic Energy Research Institute Process for producing a slow release composite
EP0211267A2 (en) * 1985-07-29 1987-02-25 American Cyanamid Company Continuous release peptide compositions
GB2209937A (en) * 1987-09-21 1989-06-01 Depiopharm S A Water insoluble polypeptides

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3976071A (en) * 1974-01-07 1976-08-24 Dynatech Corporation Methods of improving control of release rates and products useful in same
US3978203A (en) * 1974-07-12 1976-08-31 Dynatech Corporation Sustained release of pharmaceuticals from polyester matrices
US4107288A (en) * 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
US4010125A (en) * 1975-06-12 1977-03-01 Schally Andrew Victor [D-Trp6 ]-LH-RH and intermediates therefor
US4622244A (en) * 1979-09-04 1986-11-11 The Washington University Process for preparation of microcapsules
US4675189A (en) * 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
PH19942A (en) * 1980-11-18 1986-08-14 Sintex Inc Microencapsulation of water soluble polypeptides
US4349530A (en) * 1980-12-11 1982-09-14 The Ohio State University Implants, microbeads, microcapsules, preparation thereof and method of administering a biologically-active substance to an animal
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
CH661206A5 (fr) * 1983-09-23 1987-07-15 Debiopharm Sa Procede pour la preparation d'un medicament destine au traitement de maladies hormonodependantes.
JPS60181029A (ja) * 1984-02-29 1985-09-14 Toyo Jozo Co Ltd 徐放性製剤の製法
US4666704A (en) * 1985-05-24 1987-05-19 International Minerals & Chemical Corp. Controlled release delivery system for macromolecules
US4962091A (en) * 1986-05-23 1990-10-09 Syntex (U.S.A.) Inc. Controlled release of macromolecular polypeptides
JPS63218632A (ja) * 1987-03-06 1988-09-12 Japan Atom Energy Res Inst ホルモンに徐放性機能を付与した生体分解型コポリ（グルコ−ル酸／ｌ−乳酸）複合体の製造方法
US4897268A (en) * 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
DE3734223A1 (de) * 1987-10-09 1989-04-20 Boehringer Ingelheim Kg Implantierbares, biologisch abbaubares wirkstofffreigabesystem

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4483807A (en) * 1981-01-27 1984-11-20 Japan Atomic Energy Research Institute Process for producing a slow release composite
EP0211267A2 (en) * 1985-07-29 1987-02-25 American Cyanamid Company Continuous release peptide compositions
GB2209937A (en) * 1987-09-21 1989-06-01 Depiopharm S A Water insoluble polypeptides

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263108B2 (en) 2001-06-22 2012-09-11 Durect Corporation Zero-order prolonged release coaxial implants
US8889174B1 (en) 2001-06-22 2014-11-18 Durect Corporation Zero-order prolonged release coaxial implants

Also Published As

Publication number Publication date
FI97688B (fi) 1996-10-31
IL95120A0 (en) 1991-06-10
ZA905654B (en) 1991-05-29
IT9021019A0 (it) 1990-07-23
DK180790A (da) 1991-01-29
NO300304B1 (no) 1997-05-12
GB2234169A (en) 1991-01-30
NO903264D0 (no) 1990-07-23
ES2020890A6 (es) 1991-10-01
PT94842B (pt) 1997-04-30
AU5910390A (en) 1991-01-31
DK175495B1 (da) 2004-11-08
GR900100568A (en) 1991-12-10
FI903643A0 (fi) 1990-07-19
NO903264L (no) 1991-01-29
PT94842A (pt) 1991-03-20
IL95120A (en) 1994-10-07
IE902592A1 (en) 1991-02-27
CA2021767A1 (en) 1991-01-29
DK180790D0 (da) 1990-07-27
ATA154590A (de) 1993-07-15
SE9002522D0 (sv) 1990-07-27
CH679207A5 (enExample) 1992-01-15
IT9021019A1 (it) 1992-01-23
US5134122A (en) 1992-07-28
DE4023134C2 (de) 1997-04-17
SE9002522L (sv) 1991-01-29
LU87772A1 (fr) 1990-12-11
JPH0366625A (ja) 1991-03-22
AT397197B (de) 1994-02-25
IT1243357B (it) 1994-06-10
NL194858C (nl) 2003-05-06
DE4023134A1 (de) 1991-01-31
FR2650182A1 (fr) 1991-02-01
FI97688C (fi) 1997-02-10
JPH0662427B2 (ja) 1994-08-17
NL9001646A (nl) 1991-02-18
SE504279C2 (sv) 1996-12-23
GR1001215B (el) 1993-06-21
NL194858B (nl) 2003-01-06
AU619996B2 (en) 1992-02-06
IE65397B1 (en) 1995-10-18
FR2650182B1 (fr) 1992-05-15
BE1003093A3 (fr) 1991-11-19
CA2021767C (en) 1996-10-22
GB9015722D0 (en) 1990-09-05

Similar Documents

Publication Publication Date Title
GB2234169B (en) A method for preparing a sustained-release pharmaceutical peptide composition
AR244088A1 (es) Metodo para la obtencion de una preparacion farmaceutica de liberacion sostenida.
FI906249A7 (fi) Menetelmä farmaseuttisen seoksen valmistamiseksi
GB9227166D0 (en) A method for preparing pharmaceutical compositions
FI894342L (fi) Menetelmä syklosporiinia sisältävän farmaseuttisen koostumuksen valmistamiseksi
HUT54386A (en) Process for producing renin-inhibitor peptides and pharmaceutical compositions containing them
EP0467992A4 (en) Process for purifying a protein
GB9005730D0 (en) Solid pharmaceutical composition and a process for preparing same
HUT54037A (en) Process for producing retarde compositions containing water-soluble peptides
EG18603A (en) A method for the preparation of pharmaceutical composition
FI873106L (fi) Menetelmä jatkuvavapautteisen lääkevalmisteen valmistamiseksi
IL98095A0 (en) Process for preparing peptide
FI20001776L (fi) Menetelmä farmaseuttisen koostumuksen valmistamiseksi
EP0410422A3 (en) A highly absorbable pharmaceutical composition
PL285753A1 (en) Method for manufacturing indenoindolo compounds and a pharmaceutical composition
ZA882783B (en) Process for preparing a pharmaceutical composition
HUT53802A (en) Process for producing pharmaceutical preparations containing piperidino-alkanole-derivatives
GR900100364A (en) Method for preparating pharmaceutical compositions
CS649989A3 (en) Process for preparing cyclosporin a derivatives
GB9321945D0 (en) A pharmaceutical composition having anti-decrepit action a process for preparation thereof
HU907129D0 (en) Process for producing pharmaceutical preparatives
GB9123241D0 (en) A process for preparing a pharmaceutical composition
HUT55636A (en) Process for producing pharmaceutical composition
EP0593452A4 (en) METHOD FOR PRODUCING A PROTEIN MARKED WITH METAL RADIONUCLIDE.
HU9203477D0 (en) Method for preparing water-dissoluble pharmaceutical preparaive

Legal Events

Date Code Title Description
PE20 Patent expired after termination of 20 years

Expiry date: 20100716